MIG1 Glucose Repression in Metabolic Processes of Saccharomyces cerevisiae: Genetics to Metabolic Engineering

PDF - Export to EndNote - PubMed Central XML format - PubMed Central XML format - PubMed Central XML format
PMID: 31379993 (PubMed) - PMCID: PMC6626512 - View online: PubReader
Volume 11, Issue 3, July-September , Page 215 to 220
Wednesday, January 24, 2018 :Received , Wednesday, June 20, 2018 :Accepted

  • - Institute of Chemical Biology, Faculty of Natural Sciences and Engineering, Ilia State University, Tbilisi, Georgia
    - Center of Pharmaceutical Sciences, Faculty of Life Sciences, University of Vienna, Vienna, Austria

  • - Institute of Chemical Biology, Faculty of Natural Sciences and Engineering, Ilia State University, Tbilisi, Georgia
  • Corresponding author Department of Clinical Biochemistry, Faculty of Medicine, Ilam University of Medical Sciences, Ilam, Iran, Tel/Fax: +995 2221703, +98 84 32235745, E-mail: bakhtiyaribio@gmail.com
    - Department of Clinical Biochemistry, Faculty of Medicine, Ilam University of Medical Sciences, Ilam, Iran

  • - Department of Clinical Biochemistry, Faculty of Medicine, Ilam University of Medical Sciences, Ilam, Iran

  • - Section of Clinical Nutrition and Nutrigenomics, Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy

  • - Faculty of Applied Medical-Surgical Sciences, University of Rome Tor Vergata, Rome, Italy
    - CAPES Foundation, Ministry of Education of Brazil, Brasília, Brazil
  • Corresponding author Institute of Chemical Biology, Faculty of Natural Sciences and Engineering, Ilia State University, Tbilisi, Georgia, Tel/Fax: +995 2221703, +98 84 32235745, E-mail: davit_mikeladze@iliauni.edu.ge
    - Institute of Chemical Biology, Faculty of Natural Sciences and Engineering, Ilia State University, Tbilisi, Georgia


Background: Although Saccharomyces cerevisiae has several industrial applications, there are still fundamental problems associated with sequential use of carbon sources. As such, glucose repression effect can direct metabolism of yeast to preferably anaerobic conditions. This leads to higher ethanol production and less efficient production of recombinant products. The general glucose repression system is constituted by MIG1, TUP1 and SSN6 factors. The role of MIG1 is known in glucose repression but the evaluation of effects on aerobic/anaerobic metabolism by deletion of MIG1 and constructing an optimal strain brand remains unclear and an objective to be explored. 
Methods: To find the impact of MIG1 in induction of glucose-repression, the Mig1 disruptant strain (∆MIG1) was produced for comparing with its congenic wild-type strain (2805). The analysis approached for changes in the rate of glucose consumption, biomass yield, cell protein contents, ethanol and intermediate metabolites production. The MIG1 disruptant strain exhibited 25% glucose utilization, 12% biomass growth rate and 22% protein content over the wild type. The shift to respiratory pathway has been demonstrated by 122.86 and 40% increase of glycerol and pyruvate production, respectively as oxidative metabolites, while the reduction of fermentative metabolites such as acetate 35.48 and ethanol 24%. 
Results: Results suggest that ∆MIG1 compared to the wild-type strain can significantly present less effects of glucose repression. 
Conclusion: The constructed strain has more efficient growth in aerobic cultivations and it can be a potential host for biotechnological recombinant yields and industrial interests.



Introduction :

The yeast Saccharomyces cerevisiae (S. cerevisiae) with safety of handling and capable of genetic transfer system is a favorite organism for protein production. The growth of S. cerevisiae as a potential eukaryotic host requires utilizing carbon resources in optimal process. Industrial carbon sources usage by yeast slow down when glucose and fructose are present in culture media. This is commonly called carbon catabolite repression (referred to as glucose repression) 1,2
The presence  of glucose in industrial cultivation media has a negative impact upon the metabolism of other sugars. Glucose repression reduces the transcription rate of repressible genes, and is the most investigated mechanism of glucose control. So, it is of importance to develop strains in which glucose repression is relieved 3. Therefore, all sugars should be utilized, preferably simultaneously, to achieve optimal economic yield 4. Invertase (EC, the sucrose-hydrolyzing enzyme, is expressed under control of glucose repression. In S. cerevisiae, six SUC genes (SUC1 to SUC5 and SUC7) are responsible to encode Invertase of which SUC2 is the most common one 2. Invertase is encoded by SUC2 including two forms, secreted and cytoplasmic 5.
The secreted form of invertase is glycosylated and located in periplasmic space, digesting extracellular sucrose to glucose and fructose, both of which can be transported into the cell 6. The cytoplasmic form is not glycosylated, and acts physiologically to cleave sucrose, transported across the plasma membrane 7,8.  
SUC2 gene repression following glucose uptake constitutes a regulatory cascade through a large number of regulatory elements 2. Mig1p, a zinc finger DNA-binding protein, is the main involved component that mediates glucose induced repression of sugars. Inactivation of MIG1 gene derepresses the expression of invertase encoded by SUC2 9. This protein resembles the mammalian Egr and Wilms’ tumor proteins, the CreA repressor in Aspergillus nidulans and the Migl repressor in Kluyveromyces lactis 4,5
The MIG1 promoter has been reported to be auto-regulated 6. Mig1p prevents transcription of SUC2 through the mechanism that mediates the binding of the general repressor Ssn6p-Tup1p complex to the regulatory part of SUC2. Snf1 kinase regulates glucose derepression of genes required for utilization of alternative carbon sources. The main mechanism is through glucose dependent dephosphorylation of transcriptional repressor protein Mig1. One important strategy to reveal the mechanism of Mig1-mediated repression is to investigate the physiological consequences of MIG1 deletion/disruption and/or MIG1 over expression 3. No absolute evidence could well explain the physiological changes by Mig1-redundant protein in a ∆MIGl mutant, i.e. a protein that is similar to Miglp and can partly be a substitute. A second repressor, Mig2p, which is 71% identical to Miglp, as well as a related protein, YerO28, have been identified. In microarray approached combinatorial control, MIG1 and MIG2 repress a largely overlapping set of genes but MIG3 does not seem to overlap in function with MIG1 and MIG2. Instead, MIG3 down regulates the SIR2 gene responsible for gene silencing and the control of aging 8. There are two approaches to silence MIG1 gene of which one is usually accomplished by disruption and substitution of the target gene with a selecting marker introduced by homologous recombination. The second alternative approach, which has been applied and researched in plant, is antisense gene expression 9,10
In this study, the purpose was to apply the first approach to disrupt chromosomal MIG1 gene through homologous recombination with reconstructed plasmid containing inserted N and C terminals of MIG1 gene coupled with URA3 selecting marker enabling ∆MIG1 mutants to be screened. Disruption and replacement of MIG1 can derepress promoters of genes which are repressed by glucose. Prototrophic MIG1 disruptant (∆MIG1) as well as its congenic wild-type strain (2805) were analyzed for expected physiological changes in peripheral metabolism (batch cultivations on sugar mixtures) and central metabolism. During the cultivations, an attempt was made to monitor the parameters of glucose consumption, biomass production, intracellular protein content and patterns of metabolite production to understand how the effect of MIG1 removal can shift to oxidative pathway of metabolism. The strain can be optimized as a host for further processing of recombinant production with advantages of being eukaryotic.


Materials and Methods :

Preparation of YPD broth culture to grow the yeast: S. cerevisiae wild type strain 2805 was cultured on solid or liquid Yeast Peptone Dextrose (YPD), while carbohydrates were supplied at concentrations of 20 g/L 11. For physiological experiments, a medium, previously described, was used with minor modifications 12. Medium for batch cultivations consisting of glucose (28 mM), sucrose (58 mM), (NH4) 2SO4 (7.5 g/L), KH2PO4 (3.5 g/L), MgSO4• 7H2O (2.7 g/L), trace metal solution (20 ml/L), vitamin solution (2 ml/L), and antifoam 289 (50 ml/L) were used. The trace metal solution was composed of EDTA (3 g/L), CaCl2•2H2O (0.9 g/L), ZnSO4•7H2O (0.9 g/L), FeSO4•7H2O (0.6 g/L), H3BO3 (0.2 g/L), MnCl2•2H2O (155.5 mg/L), Na2MoO4•2H2O (80 mg/L), CoCl2•2H2O (60 mg/L), CuSO4•6H2O (60 mg/L), and KI (20 mg/L), adjusted to pH=4.0 with NaOH. The vitamin solution was composed of d-biotin (50 mg/L), p-aminobenzoic acid (200 mg/L), nicotinic acid (1.0 g/L), calcium pantothenate (1.0 g/L), pyridoxine HCl (1.0 g/L), thiamine, HCl (1.0 g/L), and m-inositol (25 g/L), adjusted to pH=6.5 with HCl 3. Sugars were autoclaved separately, and the vitamin solution was sterilized by filtration and added after autoclaving. To prevent bacterial growth antibiotics penicillin G, streptomycin and chloramphenicol were added to media in  concentration  100, 100 and 50 μgr/L, respectively along with adding 2% agar which can  provide YPD solid media. The preparation of the inoculum and the conditions of batch cultivation were according to the described experiment 13: a colony taken from YPD agar plate inoculated in 4 baffled Erlenmeyer shake flasks containing 250 ml YPD broth at 28°C and 100 rpm for 48 hr. The temperature was kept fixed and the pH was controlled within the range 4.9-5.0 by automatic addition of 4 M NaOH. The air flow was set to 1 vvm (4.0 L/min), and the off-gas was led through a condenser. After incubation period, media were centrifuged and washed by normal saline within 50 ml tubes in 3000 rpm for 10 min
Preparation and analysis of DNA: Total yeast DNA was extracted as described by Ausubel et al 14. To check purification of extracted DNA, quantitative control was performed by spectrophotometric method 15 and quality of DNA was checked by accuracy and sharpness of related bands in gel electrophoresis. For restriction analysis and gel electrophoresis, experiments standard protocols were followed 16. For the purification of DNA fragments used for cloning experiments, the desired fragments were separated on 0.7% agarose gels, excised and recovered from agarose, using BIOTRAP BT1000 (Schleicher & Schuell, Duren, Germany).
Oligonucleotide primers and PCR analysis: Both forward and reverse primers provided by Oligo and Blast software for each of N-fragment (before starting codon of MIG1) and C-fragment (after stop codon of MIG1) included restriction sites for EcoRI and BamHI. Primers were made by Clontech Company according to the N- and C- terminal sequences of MIG1 gene. PCR amplification of N and C terminal fragments was performed by thermocycler according to instructions followed: initial single denaturation at 94oC for 5 min, 30 cycles of denaturation at 94 for 30 s, annealing at 45oC for 45 s, extension at 72oC for 1 min and final extension at 72oC for 5 min. The correct amplification of PCR products (N-fragment of 400 bp, C-fragment of 600 bp) was confirmed by gel electrophoresis. In table 1, the oligonucleotide primers used in PCR analysis are shown.
Cloning of N and C fragments and transformation to Escherichia coli (E. coli): The amplified N and C fragments were cleaned up by PCR product purification kit (Biogen Company). The purified products enabled restricted digestion of fragments on suitable restriction sites which existed within the primers. Namely, N fragments were digested with EcoRI and BamHI enzymes and C fragments were digested with XbaI and BamHI enzymes. The restriction digestion reactions were carried out for overnight at 37oC. The enzymes were inactivated in 10 min at 65°C. After gel electrophoresis of digested fragments, 400 and 600 bp DNA bands corresponding to N-and C- fragments, respectively, were extracted from gel 16. The gel purified N- and C- fragments were inserted into plasmid pBluescript II SK (Stratagene) using Fermentase DNA cloning kit (Thermo Fisher Scientific Company). The resulted constructed plasmid pMIG1 consists of BamHI as midline restriction site between inserted N- and C-fragments. Furthermore, plasmids were transferred to Escherichia coli (E. coli) DH5α (Bethesda Research Laboratories). E. coli was transformed by electroporation using a Gene Pulser (Pulse Controller, Bio-Rad, Richmond, CA, USA) according to the manufacturer’s instructions. The growth of transformants in LB culture media containing ampicillin (100 mg/ml) and X-α-gal (as screening agent) and IPTG (as galactose metabolism inducing factor) allowed selection of white colonies consisting of pMIG1 plasmid. The recombinant pMIG1 plasmid consisted of plasmid pBluescript, N- and C- fragments digested with BanHI and inserted with selection marker, URA3, as described by Klein et al 17.
Transformation to yeast by pMIG1 plasmid: The wild strain S. cerevisiae was transformed by PEG/Li acetate method 16 to replace to produce MIG1 disrupted strains. URA3 enables recombinant yeast to synthesize required uracil for growing in uracil-lacked medium (SC-URA). 
Determining cell biomass: Produced biomass of wild and MIG1 disrupted strains was determined by using optical densitometry method. The biomass yield was obtained from the slopes of the plots of biomass and the amount of consumed sugar during exponential growth phase. 
Analysis of sugars and produced metabolites: To measure sugars and extracellular metabolites, cultivation medium was sampled, immediately filtered through a 0.45 mm pore size cellulose acetate filter. Glucose, galactose, maltose, ethanol, glycerol, acetate and pyruvate were separated on an Aminex HPX-87H ion exclusion column HPLC and were detected refractometrically or spectrophotometrically 13
Measurement of cell protein content: For the determination of cell protein content, a sample was isolated in ice beaker, centrifuged and washed three times with 5 ml of 0.9% (w:w) NaCl and resuspended in 1 ml of water, before storage at -80°C. Then, the total protein content was measured according to the Biuret method 12.


Results :

Construction of disrupted mutant yeast: The haploid wild type strain 2805 was selected to test the feasibility of suppressing effect of MIG1 by gene disruption and to simplify direct isogenic comparison of MIG1 expressing strains with that of MIG1 disrupted mutants. The confirmation of amplification of N and C fragments of MIG1 gene sequence with 400 and 600 bp, respectively, were compared to size marker (Figure 1). Insertion of N and C fragments in pBlueskript II plasmid and transformation to E. coli DH5a leading to antibiotic resistance attributed to the bacterial aminoglycoside phosphotransferase-encoding APT2 gene which is inserted between the PGK promoter and terminator. 
After replica plating to X-α-Gal medium under inducing conditions with galactose and glycerol, transformed bacterial strains were isolated (data not shown). Upon transformation of strain 2805 with pBluescript II integrated with N and C fragments of MIG1 sequence interrupted with URA3, several clones of yeast able to grow in SC-URA were isolated.
Metabolic assessment: For batch cultivations on glucose, each of the Saccharomyces strains 2805 and ∆MIG1 were grown on 40.0 g/L of glucose 3. The results were from the study of aerobic metabolism under defined conditions of glucose control. Each experiment was repeated at least three times. The achieved results were analyzed by using SPSS 21.0 (SPSS, Chicago, IL) software. All normally distributed continuous variables were demonstrated as mean.
Glucose consumption and growth rate: Glucose consumption in ∆MIG1 mutant was proceeded to wild 2805 strain by 25.0% within several batch and lag phase measurements (Figure 2A). The maximum specific growth rate of 2805 and of ∆MIG1, calculated from nine simultaneous optical density measurements demonstrated 0.39 and 0.43 h, respectively. Thus, MIG1 disruption led to 12.0% average increase of specific growth rate on glucose (Figure 2B).
Ethanol production and cell protein content: In batch cultivation, the rate of carbon flux directed to ethanol production in ∆MIG1 strain was reduced about 24.0% (C-mmol/L) of lag phase cultivation (Figure 2C). The less formation of ethanol and related anaerobic metabolites at a higher rate with ∆MIG1 than with 2805 demonstrates considerable shifted metabolism from respiro-fermentative to respiratory pathway. Intracellular protein content accounted for both strains showed 22.0% (w:w) difference to significant  increase in ∆MIG1 compared with 2805 (Figure 2D).
Glycerol, pyruvate and acetate formation: The carbon fluxes have been increased to respiratory metabolism pathway. It is indicated by more remarkable formation of oxidative metabolites markers, i.e glycerol and pyruvate which have been produced 122.86 (C-mmol/L) and 40.0% (C-mmol/L) in ∆MIG1 prominent than strain 2805, respectively.  Conversely, the decrease of fermentative metabolite of acetate by 34.58% (C-mmol/L) has been observed. The differences between the rate of metabolite production within cultivation period have been calculated and expressed as percentage (Δ%) (Figure 3). The comparison between all continuous variables was performed by using one-way analysis of variance (ANOVA). If there were statistically significant differences, then Tukey’s Post-Hoc test was applied. The values of p<0.05 were considered statistically significant.


Discussion :

Yeast has been considered as a perfect microorganism for biological studies and protein recombinant production. Safety of handling and synthesized recombinant products also capable genetic transfer systems make this organism to be widely used as a host. In yeast cells, unification of transformed DNA and chromosomes potentially occur through homologous recombination process leading to expression of different modified eukaryotic proteins.
The major types of yeast being used in biotechnology as gene expression tools are S. cerevisiae, Han-senula polymorpha, and Kluyveromyces lactis. For several advantages, S. cerevisiae is well selected for heterologous protein production. In this research, the chromosomal metabolic gene, MIG1, disrupted by homologous recombination through antisense technique using upward and downward, N- and C-, fragments of MIG1 gene was applied to study the metabolic effects on yeast. Lateral fragments, N and C, after amplification were inserted in yeast specified vector, pTcURA3 alongside metabolic selection marker URA3. After transformation to yeast, MIG1 gene would be replaced with URA3 marker. It can be happened by recombination between its lateral N and C fragments and resembles sequences already inserted into the vector lateral to URA3 marker. This transformation enables the yeast to synthesize required nutrient uracil. In fact, through this method, MIG1 disrupted strain can be screened by growth on uracil negative medium. Then, further analyses of central and peripheral metabolic pathway have been done to approach variations between mutant and intact wild strain.
The glucose accessibility is the most important environmental factor to regulate oxidation and fermentation metabolic pathways of Saccharomyces i.e., glucose concentration in batch inhibits the utilization of other carbon resources, the catabolic inhibition 18. Hexokinase PII starts glucose inhibition cascade 18 and Snf1p as a signal transductor phosphorylates mig1p (regulatory zinc finger protein of MIG1 gene) which makes inhibitory complex with Ssn6 (cyc8)-tup1 components (Carlson, 1987) and binds to promoter of glucose controlled genes. The MIG1 gene was cloned in 1990 for the first time 4. Deletion of MIG1 demonstrates a greater impact on peripheral functions than on central metabolism. 
There are recent evidences which persist on the role of Hexokinase 2 (Hxk2) in regulation of DNA-binding repressor proteins of Mig1 protein and glucose repression signal in nucleus. Hxk2 acts as an intracellular glucose sensor that operates by changing its conformation in response to cytoplasmic glucose levels and regulates dephosphorylation of Mig1 19,20. In the present study, ∆MIG1 strain 2805 could utilize more glucose in comparison to the wild strain within the first 12 hr to reach to the zero point. When the glucose concentration is high, Snf1p is inactivated and non-phosphorylated mig1p would remain in nucleus and represses transcription of dependent genes. Conversely, in low concentration of cultivation glucose, phosphorylated MIG1p can migrate to cytoplasm and leads to removal of repression status. The deletion of MIG1 can eliminate glucose repression partially from peripheral functions, rather than completely from central metabolic functions. The outcome of this deletion has been considered significant in industry because glucose is the most useful sugar among the carbon resources for yeast in industry process. This can delay uptake of other sugars resulting in elongation of production process. Therefore, an effective alleviation of glucose control would help to achieve a better process economy for the cultivation of baker’s yeast, alcohol fermentation, bread-making and recombinant protein production 17. In some studies, it has been proved that disruption of MIG1 cannot remove the entire glucose repression effect from galactose, maltose and sucrose metabolism. Therefore, substantial MIG1-independent glucose control mechanisms exist for the GAL, MAL and SUC systems 21. On the other hand, glucose through MIG1 regulation process has several repression effects on the expression of GAL family genes like GAL2, GAL3, GAL4, and GAL80. They are involved in the metabolism of galactose and highly affected by MIG1 disruption 22,23. Imp2p is a MIG1 related regulator of GAL genes and has the positive effect on glucose derepression of the maltose, galactose and raffinose utilization pathways and in resistance to thermal, oxidative or osmotic stress of S. cerevisiae 23. The finding that CAT8 was derepressed in a ∆MIGl strain, whereas Cat8-controlled FBPl, PCKl and ZCLl were not, gives a clear hint of the existence of other repressors such as MIG2 or a post-translational modification of an effector such as the phosphorylation of the derepressor Cat8 16.
The study of the effect of simultaneous deletion of MIG1/MIG2 genes on physiology of Saccharomyces exhibited that glucose control of maltose and sucrose metabolism was derepressed in disrupted MIG1/MIG2 3,24. However, the lag phase of galactose cultivation diminished and further deletion of MIG2 could not affect glucose dependent metabolism of galactose. The MIG1 gene was silenced by antisense MIG1 expression 10. The results of evaluation of glucose consumption, cell biomass production and intracellular protein contents by Optical Densitometry (OD) method and Invertase enzymatic activity assays demonstrated the more flexible growth of ∆MIG1 strains under the sufficient amount of oxygen and glucose. This is evidential for removal of glucose repression effects and impressive shift to more oxidative metabolism in comparison to wild strains. Yeast cell cultivations are effectively stressed by chemical metabolites produced within growth phase namely acids and high percentage of ethanol which can suppress the yeast growth. Deletion of MIG1 can switch fermentative metabolism to aerobic pathway. It results in the production of less fermentative products like ethanol and acetate. Meanwhile, the promotion of Krebs cycle leads to more acidic derivative products such as glycerol and pyruvate. The data from the current research approved the similar concept 12,25. However, the increase of glycerol production in mutant strain is much prominent than what has been reported in similar studies 10,13. Such modifications in peripheral and central metabolic functions could satisfy industrial interests which attempt to have optimal engineered strains for recombinant production.


Conclusion :

This study showed the amount of ethanol measured by HPLC method in mutant and wild strain cultivations which determined less production of ∆MIG1. Enhancement of biomass production in ∆MIG1 strains can lead to higher amount of intracellular protein content and carbohydrates. In the current research, results of strain ∆MIG1 2805 could confirm similar achievements rather than wild types. As to peripheral functions, efforts have already been exerted in production of partially derepressed galactose, maltose and sucrose metabolisms. For central functions, industrial interest could promote attempts in the metabolic engineering of strains that exhibit higher specific growth rates for baker’s yeast or recombinant protein production, or of distiller’s yeast strains that give higher ethanol yields.


<p>Figure 1. Amplified N fragment (400 <em>bp</em>) and C fragment (600 <em>bp</em>) of MIG1 chromosomal gene of Saccharomyces Cerevisiae next to the size marker. The size marker (SM) contains of bands for each equals to 100 <em>bp.</em></p>

Figure 1. Amplified N fragment (400 bp) and C fragment (600 bp) of MIG1 chromosomal gene of Saccharomyces Cerevisiae next to the size marker. The size marker (SM) contains of bands for each equals to 100 bp.

<p>Figure 2. Concentration of A) glucose, B) cell mass, C) ethanol, and D) cell protein in batch cultivations of wild strains 2805(■) and ∆MIG1 (MIG1 disrupted mutant) (▲ ) on a medium with glucose control conditions. The data achieved of three independent experiences and calculated mean values have been demonstrated for each amount on the related graph, (n=3), p&lt;0.05, significantly different characteristics of mutant strain from respective wild strain.</p>

Figure 2. Concentration of A) glucose, B) cell mass, C) ethanol, and D) cell protein in batch cultivations of wild strains 2805(■) and ∆MIG1 (MIG1 disrupted mutant) (▲ ) on a medium with glucose control conditions. The data achieved of three independent experiences and calculated mean values have been demonstrated for each amount on the related graph, (n=3), p<0.05, significantly different characteristics of mutant strain from respective wild strain.

<p>Figure 3. Different production ratio (Percent variation &Delta;%) of metabolite parameter (Acetic acid, Glycerol, Pyruvic acid) in batch cultivations of wild strains 2805 (■) and ∆MIG1(MIG1 disrupted mutant) (■) on a medium with glucose control conditions.</p>

Figure 3. Different production ratio (Percent variation Δ%) of metabolite parameter (Acetic acid, Glycerol, Pyruvic acid) in batch cultivations of wild strains 2805 (■) and ∆MIG1(MIG1 disrupted mutant) (■) on a medium with glucose control conditions.

<p>Table 1. Oligonucleotide primers used in PCR analysis</p>

Table 1. Oligonucleotide primers used in PCR analysis

References :
  1. Xu JR, Zhao XQ, Liu CG, Bai FW. Improving xylose utilization of Saccharomyces cerevisiae by expressing the MIG1 mutant from the self-flocculating yeast SPSC01. Protein Pept Lett 2018;25(2):202-207.   [PubMed]
  2. Galello F, Pautasso C, Reca S, Cañonero L, Portela P, Moreno S, et al. Transcriptional regulation of the protein kinase a subunits in Saccharomyces cerevisiae during fermentative growth. Yeast 2017;34(12):495-508.   [PubMed]
  3. Klein CJL, Rasmussen JJ, Rønnow B, Olsson L, Nielsen J. Investigation of the impact of MIG1 and MIG2 on the physiology of Saccharomyces cerevisiae. J Biotech 1999;68(2-3):197-212.   [PubMed]
  4. Nehlin JO, Ronne H. Yeast MIG1 repressor is related to the mammalian early growth response and Wilms tumour finger proteins. EMBO J 1990;9(9):2891-2898.   [PubMed]
  5. Dowzer CEA, Kelly LM. Analysis of the creA gene, a regulator of carbon catabolite repression in Aspergillus nidulans. Mol Cell Biol 1991;11(11):5701-5709.   [PubMed]
  6. Entian KD, Schuller HJ. Glucose repression (carbon catabolite repression) in yeast. In: Zimmermann FK, Entian KD (eds). Yeast Sugar Metabolism. Lancaster, Pennsylvania; Technomic Publishing Company; 1997. p. 409-434.
  7. Shashkova S, Wollman AJM, Leake MC, Hohmann S. The yeast Mig1 transcriptional repressor is dephosphorylated by glucose-dependent and -independent mechanisms. FEMS Microbiol Lett 2017;364(14):fnx133.
  8. Westholm OJ, Nordberg N, Murén E, Ameur A, Komorowski J, Ronne H. Combinatorial control of gene expression by the three yeast repressors Mig1, Mig2 and Mig3. BMC Genomics 2008;9:601.   [PubMed]
  9. Atkins D, Arndt GM, Izant JG. Antisense gene expression in yeast. Biol Chem Hoppe-Seyler 1994;375 (11):721-729.   [PubMed]
  10. Olsson L, Larsen ME, Rønnow B, Mikkelsen JD, Nielsen J. Silencing MIG1 in Saccharomyces cerevisiae: Effects of antisense MIG1 expression and MIG1 gene disruption. Appl Environ Microbiol 1997;63(6):2366-2371.   [PubMed]
  11. Rose M, Winston F, Hieter P. Methods in yeast genetics: a laboratory course manual. Cold Spring Harbor, New York: Cold Spring Harbor Laboratory Press; 1990. 198 p.
  12. Verduyn C, Postma E, Scheffers WA, van Dijken JP. Physiology of Saccharomyces cerevisiae in anaerobic glucose-limited chemostat cultures. J Gen Microbiol 1990;136(3):395-403.   [PubMed]
  13. Klein CJL, Olsson L, Rønnow B, Mikkelsen JD, Nielsen J. Alleviation of glucose repression of maltose metabolism by MIG1 disruption in Saccharomyces cerevisiae. Appl Environ Microbiol 1996;62(12):4441-4449.   [PubMed]
  14. Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JG, Smith JA, et al. Short protocols in molecular biology, 3rd ed. New York: John Wiley & Sons;1995. 836 p.
  15. Rothstein RJ. One step gene disruption in yeast. Methods Enzymol 1983;101:202-211.   [PubMed]
  16. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor, New York: Cold Spring Harbor Laboratory Press; 1989. 1626 p.
  17. Klein CJL, Olsson L, Nielsen J. Glucose control in Saccharomyces cerevisiae: the role of MIG1 in metabolic functions. Microbiology 1998;144(Pt 1):13-24.   [PubMed]
  18. Entian KD, Barnett JA. Regulation of sugar utilization by Saccharomyces cerevisiae. Trends Biochem Sci 1992;17(12):506-510.   [PubMed]
  19. Vega M, Riera A, Fernández-Cid A, Herrero P, Moreno F. Hexokinase 2 is an intracellular glucose sensor of yeast cells that maintains the structure and activity of Mig1 protein repressor complex. J Biol Chem 2016;291(14):7267-7285.   [PubMed]
  20. Peláez R, Herrero P, Moreno F. Functional domains of yeast hexokinase 2. Biochem J 2010;432(1):181-190.   [PubMed]
  21. Cao H, Yue M, Li S, Bai X, Zhao X, Du Y. The impact of MIG1 and/or MIG2 disruption on aerobic metabolism of succinate dehydrogenase negative Saccharomyces cerevisiae. Appl Microbiol Biotechnol 2011;89(3):733-738.   [PubMed]
  22. Prasad V, Venkatesh KV. Stochastic analysis of the GAL genetic switch in Saccharomyces cerevisiae: modeling and experiments reveal hierarchy in glucose repression. BMC Syst Biol 2008;2:97.   [PubMed]
  23. Alberti A, Lodi T, Ferrero I, Donnini C. MIG1-dependent and MIG1-independent regulation of GAL gene expression in Saccharomyces cerevisiae: role of Imp2p. Yeast 2003;20(13):1085-1096.   [PubMed]
  24. Westholm JO, Nordberg N, Murén E, Ameur A, Komorowski J, Ronne H. Combinatorial control of gene expression by the three yeast repressors Mig1, Mig2 and Mig3. BMC Genomics 2008;9:601.   [PubMed]
  25. Herbert D, Phipps PJ, Strange RE. Carbohydrate analysis. In: Norris, JR, Ribbons DW (eds). Methods in Microbiology, vol. 5B. London, UK: Academic Press; 1971. p. 209-344.